AI주식인사이트AI Stock Insight
C

큐리오시스

494120KOSDAQ

43.5 / 100

Reference Date: 2026-10-23

Financial Score15.0 / 40
News Sentiment12.5 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 2.8% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Curiosys is a bio small parts supplier established in 2015, specializing in lab automation solutions. The company develops, produces, and sells bio research equipment, lab automation products, and medical devices, with key offerings including live-cell imaging systems (Celloger®), cell purification systems (Cellpuri®), and digital pathology systems (MSP®). Recognized globally with awards such as R&D100 and CES Innovation Awards, Curiosys leverages its ISO and GMP-certified production facility in Yongin, Gyeonggi, to enhance its global manufacturing capabilities.

Number of Employees

93people

Average Salary

47.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
4.31Industry Average 1.200.0Point

3.6x industry avg (risky)

ROE
-41.49Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
9.88Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 3.0 / 10 points
Revenue Growth Rate
1.5 / 3

Operating Profit Growth Rate
1.5 / 3

ROE Trend
0.0 / 4

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 7,970Won52-week high 88,00052-week low 6,930
1-month return4.0Point

1m +2.84% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral기업설명회(IR)개최2026-10-06